Beyond RECIST 1.1: The AI Endpoint Playbook for Modern Oncology Trials
Dr. Dereck Mush, MD, MBAInvestor
LSX USA Congress
A high level partnering and investment conference for life science, medtech, and digital health executives.
- When
- September, Early September
- Where
- Boston, USAView on Google Maps
- Format
- In person
- Organiser
- LSX
- Region
- North America
- Scale
- About 500 attendees
- Founded
- 2018
The Signal
The LSX USA Congress is an annual investment and partnering conference held in Boston. Organized by LSX, the event focuses on connecting life science, medtech, and digital health executives with global investors. The programming addresses corporate strategy, fundraising, and strategic licensing deals. The event utilizes a structured partnering platform to facilitate pre scheduled meetings between companies and capital providers. It provides a focused environment for executive level matchmaking.
What to expect
- Venture funding announcements
- Licensing and asset acquisition deals
- Market entry strategy panel discussions
- Investor roundtable feedback
Who is in the room
Biotech CEOs, medical device executives, digital health founders, venture capitalists, and pharma business development leads attend.
Background
Developed to translate the successful European LSX Congress model to the North American life sciences market. It has established itself as a highly productive partnering venue, bypassing broad marketing tracks for direct commercial discussions. It has grown consistently alongside Boston's biotechnology ecosystem.
Related events
Running this event, or spotted something out of date?
Related reading
Dr. Dereck Mush, MD, MBAKeep exploring